Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Alterations in the ubiquitin-proteasome system (UPS) have been reported in several neurodegenerative disorders characterized by protein misfolding and aggregation, including the polylgutamine diseases. Machado-Joseph disease (MJD) or Spinocerebellar Ataxia type 3 is caused by a polyglutamine-encodin...
Main Authors: | Mário N Laço, Luisa Cortes, Sue M Travis, Henry L Paulson, A Cristina Rego |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3435318?pdf=render |
Similar Items
-
Valosin-Containing Protein (VCP/p97) Is a Potential Antiviral Target against Mononegavirales
by: Victor Latorre, et al.
Published: (2020-06-01) -
Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants
by: Ting Zhang, et al.
Published: (2017-03-01) -
A Determination of p97/VCP (Valosin Containing Protein) and SVIP (Small VCP Interacting Protein) Expression Patterns in Human Testis
by: Akgül Arıcı, et al.
Published: (2023-06-01) -
Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
by: Adam Amlani, et al.
Published: (2023-01-01) -
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
by: Marta del Rio Oliva, et al.
Published: (2022-12-01)